HPLC purity
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
GLP-1 family · research-use
Retatrutide OEM supply.
Research use, worldwide.
Lyophilized retatrutide (triple GLP-1 / GIP / glucagon receptor research compound) for research labs and private-label brand evaluation worldwide. ≥99% HPLC purity target, batch-linked COA containing chromatographic purity and molecular-weight identity results.
!
Research use — supplied as research peptides; buyers confirm local compliance
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework, with public comment open through 2026-06-29. Pending finalization, this compound is positioned for research and private-label brand evaluation worldwide. Read the GLP-1 2026 update →
Lot RET-10HPLC ≥ 99%MS confirmed5 / 10 / 15 / 20 mg
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Retatrutide |
|---|---|
| CAS number | 2381089-83-2 |
| Class | Triple GLP-1 / GIP / glucagon receptor agonist (research) |
| Molecular weight | Confirmed against available documentation for the applicable product, specification and lot |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 100 mg |
| Documentation | Batch-linked COA containing chromatographic purity and molecular-weight identity results for the confirmed lot |
| Distribution scope | Research use, worldwide |
| Storage | 2–8 °C protected from light; long-term −20 °C |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 5–10 days |
| Production lot | 500–2,000 vials | 14–21 days |
| OEM repeat | 2,000+ vials | 21–28 days, scheduled |
All retatrutide quotes require a destination country and buyer track. Inquiries from US regulated facilities are answered with the regulatory bulk-substance framework proposal and routed to non-GLP-1 alternatives.
Documentation
Every Retatrutide lot ships with a batch document pack for the production lot.
Batch-linked COA with chromatographic purity, molecular-weight identity, water-content and storage results. Buyer track and destination confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Retatrutide reference profile.
Lot traceability
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Common Retatrutide questions from B2B buyers.
How is retatrutide supplied?
On 2026-04-30 the FDA proposed removing GLP-1 medications from the regulatory bulk-substance framework. While retatrutide itself is the target of separate development programs, Pepti supplies it as a research peptide worldwide for research and private-label brand evaluation; buyers confirm local compliance.
Which markets do you serve for retatrutide?
Latin America, Southeast Asia, parts of the Middle East, and select EMEA distributors with appropriate local registration.
Can research labs source retatrutide?
Yes — lyophilized retatrutide is supplied for laboratory research with a COA containing chromatographic purity and molecular-weight identity results. Research inquiries are reviewed before quoting.
What is the MOQ?
Sample lots from 1 kit (10 vials); production lots from 500 vials with tier pricing.
What does your COA report?
HPLC purity (target ≥99%), MS identity, water content, related-substance profile on request, and lot traceability tied to the document pack.
Related compounds
Other GLP-1 family compounds.
Current Batch COA
Open the Retatrutide Certificate of Analysis.
Batch-linked COA PDF for each Retatrutide specification below, with the reported chromatographic purity and molecular-weight identity results. Independent local verification is welcome. Confirmed quality issues are eligible for replacement or refund under the quality policy.
Open 5 mg COA PDF · PEP260706-RT5RecordOpen 10 mg COA PDF · PEP260712-RT10RecordOpen 15 mg COA PDF · PEP260707-RT15RecordOpen 20 mg COA PDF · PEP260819-RT20RecordOpen 30 mg COA PDF · PEP260716-RT30RecordOpen 40 mg COA PDF · PEP260702-RT40RecordOpen 50 mg COA PDF · PEP260724-RT50RecordOpen 60 mg COA PDF · PEP260706-RT60RecordOpen 100 mg COA PDF · PEP260728-RT100Record